康龙化成:拟投资30亿元建年产200吨医药中间体项目 分期至2030年完成

财中社
May 27

  5月27日,康龙化成(300759/03759)发布公告,公司计划通过全资子公司康龙化成(绍兴)新药生产有限公司,在绍兴市上虞区投资建设年产200吨医药中间体及API项目。

  项目的总投资金额为30亿元,旨在扩大高端医药中间体及原料药的产能规模,强化绿色制造技术的应用能力,并提升公司的CDMO服务能力。项目建设将分为两期,预计一期工程于2028年投入使用,二期工程于2030年投入使用。

  2026年一季度,康龙化成实现收入35.78亿元,归母净利润3.35亿元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10